title: [Clinical efficacy of immunostimulating drugs in treatment of purulent infections].
abstract: 81 patients with the acute soft tissue purulent infections were divided in 4 groups and treated with the use of traditional means without immunostimulating drugs; with immunoglobulins; with derinate and combination of both, respectively. The last treatment modality demonstrated maximal clinical efficacy. That is the decrease of the wound contamination period and inflammatory process; acceleration of granulation and epithelization. Clinical recovery was accompanied by marked positive changes of cell and humoral immune status.
authors.forename: A M
authors.initials: AM
authors.lastname: Zemskov
authors.forename: V M
authors.initials: VM
authors.lastname: Zemskov
authors.forename: A I
authors.initials: AI
authors.lastname: Tokmakov
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000009:adverse effects; D000328:Adult; D000368:Aged; D004247:DNA / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007136:Immunoglobulins / Q000008:administration & dosage* / Q000009:adverse effects; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D007158:Immunologic Techniques; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D018461:Soft Tissue Infections / Q000150:complications / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D013492:Suppuration / Q000150:complications / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; C541364:Derinat; D007136:Immunoglobulins; D004247:DNA